Assessment of HaloPlex Amplification for Sequence Capture and Massively Parallel Sequencing of Arrhythmogenic Right Ventricular Cardiomyopathy–Associated.

Slides:



Advertisements
Similar presentations
Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next- Generation Sequencing Data  David H. Spencer, Haley J. Abel, Christina.
Advertisements

Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
Triplet Repeat Primed PCR Simplifies Testing for Huntington Disease
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
Assessment of HaloPlex Amplification for Sequence Capture and Massively Parallel Sequencing of Arrhythmogenic Right Ventricular Cardiomyopathy–Associated.
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Implementation of a Reliable Next-Generation Sequencing Strategy for Molecular Diagnosis of Dystrophinopathies  Melissa Alame, Delphine Lacourt, Reda.
High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
In Silico Proficiency Testing for Clinical Next-Generation Sequencing
Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next- Generation Sequencing Data  David H. Spencer, Haley J. Abel, Christina.
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes  Paula Paulo, Pedro.
Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use  Liwen Xu, Xiaoqing You, PingPing.
Impact of Mutation Type and Amplicon Characteristics on Genetic Diversity Measures Generated Using a High-Resolution Melting Diversity Assay  Matthew.
High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants.
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data  David H. Spencer,
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications  Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann,
False Positives in Multiplex PCR-Based Next-Generation Sequencing Have Unique Signatures  Chad M. McCall, Stacy Mosier, Michele Thiess, Marija Debeljak,
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Annotation of Sequence Variants in Cancer Samples
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Triplet Repeat Primed PCR Simplifies Testing for Huntington Disease
Next Generation Sequencing for Clinical Diagnostics-Principles and Application to Targeted Resequencing for Hypertrophic Cardiomyopathy  Karl V. Voelkerding,
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Annotation of Sequence Variants in Cancer Samples
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
Christopher M. Watson, Nick Camm, Laura A
CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang,
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Getting Things Backwards to Prevent Primer Dimers
Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings  Ira M. Lubin, Nazneen Aziz,
Eric Samorodnitsky, Jharna Datta, Benjamin M
Christine L. Baker, Cecily P. Vaughn, Wade S. Samowitz 
SeqSharp The Journal of Molecular Diagnostics
Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs , ABCB11 rs , and RNF7 rs Genotypes in Chronic.
Somak Roy, Christopher Coldren, Arivarasan Karunamurthy, Nefize S
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes  Mia Y. Platt,
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Catherine E. Keegan, Anthony A. Killeen 
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
Rapid Next-Generation Sequencing Method for Prediction of Prostate Cancer Risks  Viacheslav Y. Fofanov, Kinnari Upadhyay, Alexander Pearlman, Johnny Loke,
The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform  Kristin.
Utility of NIST Whole-Genome Reference Materials for the Technical Validation of a Multigene Next-Generation Sequencing Test  Bennett O.V. Shum, Ilya.
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
Conventional and Single-Molecule Targeted Sequencing Method for Specific Variant Detection in IKBKG while Bypassing the IKBKGP1 Pseudogene  Glynis Frans,
Iris Schrijver, Tiffanee J. Lenzi, Carol D. Jones, Marla J
Detailed Characterization of Alterations of Chromosomes 7, 9, and 10 in Glioblastomas as Assessed by Single-Nucleotide Polymorphism Arrays  Inês Crespo,
Syed Hussain Askree, Lawrence N
Mutation Analysis of SLC26A4 for Pendred Syndrome and Nonsyndromic Hearing Loss by High-Resolution Melting  Neng Chen, Lisbeth Tranebjærg, Nanna Dahl.
External Quality Assessment for Detection of Fetal Trisomy 21, 18, and 13 by Massively Parallel Sequencing in Clinical Laboratories  Rui Zhang, Hongyun.
A Variant Detection Pipeline for Inherited Cardiomyopathy–Associated Genes Using Next-Generation Sequencing  Théo G.M. Oliveira, Miguel Mitne-Neto, Louise.
Genomic Technologies and the New Era of Genomic Medicine
A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick.
Next-Generation Sequencing for Infectious Disease Diagnosis and Management  Martina I. Lefterova, Carlos J. Suarez, Niaz Banaei, Benjamin A. Pinsky  The.
Dale Muzzey, Shera Kash, Jillian I. Johnson, Laura M
Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next- Generation Sequencing Panel  Fengqi Chang, Liu Liu, Erica Fang, Guangcheng.
Strategy for Robust Detection of Insertions, Deletions, and Point Mutations in CEBPA, a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes  Rajesh R. Singh, Keyur P. Patel, Mark J.
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

Assessment of HaloPlex Amplification for Sequence Capture and Massively Parallel Sequencing of Arrhythmogenic Right Ventricular Cardiomyopathy–Associated Genes  Anna Gréen, Henrik Gréen, Malin Rehnberg, Anneli Svensson, Cecilia Gunnarsson, Jon Jonasson  The Journal of Molecular Diagnostics  Volume 17, Issue 1, Pages 31-42 (January 2015) DOI: 10.1016/j.jmoldx.2014.09.006 Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Bioinformatics overview. In pipeline 1 (the recommended bioinformatics pipeline from the HaloPlex development team), two versions of Burrows-Wheeler Aligner (BWA) for paired-end analysis were evaluated for comparison: bwa-0.6.1-sampe and bwa-0.7.4-mem. In pipeline 2, the data were analyzed using SureCall software. The adaptor removal algorithm in SureCall is not known to us and, thereby, is indicated by a question mark. In the version of SureCall used herein, bwa-0.6.1 was used as aligner and SAMtools as variant caller. Pipeline 3, composed of custom scripts relying on bwa-0.7.4-mem single-end analysis and SAMtools-0.1.18, is described in detail in Materials and Methods with code provided in Supplemental Code S1. GATK, Genome Analysis Toolkit. The Journal of Molecular Diagnostics 2015 17, 31-42DOI: (10.1016/j.jmoldx.2014.09.006) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Quality of sequencing reads. FastQC per base quality scores for arrhythmogenic right ventricular cardiomyopathy panel design 1, where A represents a typical example of forward reads and B the reverse reads. A quality score of 10, 20, or 30 means that the probability that the base is called wrong is 10%, 1%, or 0.1%, respectively. Base quality scores are generally >Q30, with a slight drop at the end of each read. The central red line indicates the median value; the yellow boxes, the inter-quartile range (25% to 75%); the upper and lower whiskers, the 10% and 90% points; the blue line, the mean quality. The Journal of Molecular Diagnostics 2015 17, 31-42DOI: (10.1016/j.jmoldx.2014.09.006) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Sequencing quality in Context-Specific Sequencing Error motif. Integrative Genomics Viewer screenshot of a .vcf file containing called variants (top track) and a .bam file containing actual reads aligned to hg19 (middle track) for part of DSP exon 1 in a arrhythmogenic right ventricular cardiomyopathy-patient. Bases deviating from the hg19 reference are color coded. A false homozygous variant (insertion) was found in the .vcf file (top track). In the middle track, the actual reads are visualized in the .bam file. The presence of reads of variable length was untypical for amplicon-based assays. Also, the many faint color-coded bases demonstrated the presence of erroneous bases of low quality. The Journal of Molecular Diagnostics 2015 17, 31-42DOI: (10.1016/j.jmoldx.2014.09.006) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Nonrandom sequencing errors in the presumptive Context-Specific Sequencing Errrors motif of DSP exon 1 from an arrhythmogenic right ventricular cardiomyopathy patient. Bwa-0.7.4-mem was used for alignment of the HaloPlex reads to hg19. The figure shows the chaotic results as visualized in the SAMtools-0.18.1 mpileup format. The first line in each block consists of chromosome, 1-based coordinate, reference base, and the number of reads covering the site. The second line includes read bases and the third line base qualities. The dots and commas in the read bases string represent reads with the reference nucleotide in the forward and reverse direction, respectively. Capital and lowercase letters represent reads with an alternative base in the forward and reverse direction, respectively. The third line shows the Phred score quality of bases, ie, Q scores, which are logarithmically linked to error probabilities and coded by ASCII numbers minus 33. For example, the ASCII of the character is 39. Hence, a corresponding base on the line above has a Q score of 39 – 33 = 6, which means that there is a 25% chance that it is a false call. Statistically, a “c” instead of “t” at chr6:7542171 (in the middle of the figure) should have a fair chance of being correct, despite the low Q scores. However, every “c” on that line represents a false call. The Journal of Molecular Diagnostics 2015 17, 31-42DOI: (10.1016/j.jmoldx.2014.09.006) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions